These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22927910)
1. A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells. Zhang X; Meng J; Wang ZY PLoS One; 2012; 7(8):e41613. PubMed ID: 22927910 [TBL] [Abstract][Full Text] [Related]
2. Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells. Zhang XT; Ding L; Kang LG; Wang ZY Oncol Rep; 2012 Jun; 27(6):2057-65. PubMed ID: 22426783 [TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells. Zhang X; Ding L; Kang L; Wang ZY PLoS One; 2012; 7(1):e30174. PubMed ID: 22276155 [TBL] [Abstract][Full Text] [Related]
5. Urokinase receptor primes cells to proliferate in response to epidermal growth factor. Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637 [TBL] [Abstract][Full Text] [Related]
6. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells. Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008 [TBL] [Abstract][Full Text] [Related]
7. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Filardo EJ; Quinn JA; Bland KI; Frackelton AR Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579 [TBL] [Abstract][Full Text] [Related]
8. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation. Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347 [TBL] [Abstract][Full Text] [Related]
10. c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling. Donepudi M; Resh MD Cell Signal; 2008 Jul; 20(7):1359-67. PubMed ID: 18448311 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Biswas DK; Cruz AP; Gansberger E; Pardee AB Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013 [TBL] [Abstract][Full Text] [Related]
12. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. Lee RJ; Albanese C; Stenger RJ; Watanabe G; Inghirami G; Haines GK; Webster M; Muller WJ; Brugge JS; Davis RJ; Pestell RG J Biol Chem; 1999 Mar; 274(11):7341-50. PubMed ID: 10066798 [TBL] [Abstract][Full Text] [Related]
13. Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts. Lee MK; Smith SM; Murray S; Pham LD; Minoo P; Nielsen HC Am J Respir Cell Mol Biol; 2014 Jul; 51(1):114-24. PubMed ID: 24484548 [TBL] [Abstract][Full Text] [Related]
14. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells. Sato K; Kimoto M; Kakumoto M; Horiuchi D; Iwasaki T; Tokmakov AA; Fukami Y Genes Cells; 2000 Sep; 5(9):749-64. PubMed ID: 10971656 [TBL] [Abstract][Full Text] [Related]
15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Huang Y; Li X; Jiang J; Frank SJ Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991 [TBL] [Abstract][Full Text] [Related]
16. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line. Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633 [TBL] [Abstract][Full Text] [Related]
17. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Xu KP; Yin J; Yu FS Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022 [TBL] [Abstract][Full Text] [Related]
18. Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells. Yang SH; Chien CM; Su JC; Chen YL; Chang LS; Lin SR J Biochem Mol Toxicol; 2008; 22(6):396-404. PubMed ID: 19111001 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes. Nunes M; Shi C; Greenberger LM Mol Cancer Ther; 2004 Jan; 3(1):21-7. PubMed ID: 14749472 [TBL] [Abstract][Full Text] [Related]
20. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]